Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold Atkins

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|July 21, 2020
Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort studyRoy Khalife, Joshua Montroy, Emma J M Grigor, et al.
Transfusion Medicine Reviews|April 6, 2019
Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-AnalysisEmma J M Grigor, Dean Fergusson, Natasha Kekre, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
Real-World Selection of Patients for Allogeneic HCT at a Single Centre: Lack of a Suitable Donor and Other Reasons for Not ProceedingMadeline Monaghan, An Duong, Kalina Abrol, et al.
Regenerative Medicine|October 2, 2012
Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translationTania Bubela, Amir Reshef, Matthew D Li, et al.
Pharmacoeconomics|September 7, 2022
Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived ExperienceMackenzie Wilson, Kednapa Thavorn, Terry Hawrysh, et al.
BMJ Open|March 20, 2021
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trialGisell Castillo, Manoj M Lalu, Sarah Asad, et al.
JAMA Neurology|April 5, 2016
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell TransplantationAdam Bryant, Harold Atkins, C Elizabeth Pringle, et al.
Research Involvement and Engagement|October 19, 2020
Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trialsMadison Foster, Dean A Fergusson, Terry Hawrysh, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 25, 2021
Autologous Hematopoietic Stem Cell Transplantation for Chronic Inflammatory Demyelinating PolyradiculoneuropathyJosée Masson-Roy, Ari Breiner, Jodi Warman-Chardon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2010
Synergistic interaction between oncolytic viruses augments tumor killingFabrice Le Boeuf, Jean-Simon Diallo, J Andrea McCart, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|July 21, 2020
Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort studyRoy Khalife, Joshua Montroy, Emma J M Grigor, et al.
Transfusion Medicine Reviews|April 6, 2019
Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-AnalysisEmma J M Grigor, Dean Fergusson, Natasha Kekre, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
Real-World Selection of Patients for Allogeneic HCT at a Single Centre: Lack of a Suitable Donor and Other Reasons for Not ProceedingMadeline Monaghan, An Duong, Kalina Abrol, et al.
Regenerative Medicine|October 2, 2012
Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translationTania Bubela, Amir Reshef, Matthew D Li, et al.
Pharmacoeconomics|September 7, 2022
Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived ExperienceMackenzie Wilson, Kednapa Thavorn, Terry Hawrysh, et al.
BMJ Open|March 20, 2021
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trialGisell Castillo, Manoj M Lalu, Sarah Asad, et al.
JAMA Neurology|April 5, 2016
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell TransplantationAdam Bryant, Harold Atkins, C Elizabeth Pringle, et al.
Research Involvement and Engagement|October 19, 2020
Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trialsMadison Foster, Dean A Fergusson, Terry Hawrysh, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 25, 2021
Autologous Hematopoietic Stem Cell Transplantation for Chronic Inflammatory Demyelinating PolyradiculoneuropathyJosée Masson-Roy, Ari Breiner, Jodi Warman-Chardon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2010
Synergistic interaction between oncolytic viruses augments tumor killingFabrice Le Boeuf, Jean-Simon Diallo, J Andrea McCart, et al.
Pageof 8